Home | Business News | Browse by Publication | B | Biotech Week

Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS).

Publication: Biotech Week
Publication Date: 11-NOV-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced it has received marketing authorization in the European Union for rilonacept, an interleukin-1 blocker, for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) with severe symptoms, including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), in adults and children aged 12 years and older. Marketing authorization for rilonacept was granted by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) under exceptional circumstances (see also Regeneron Pharmaceuticals, Inc.)....

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Biotech Week
State Employees' Credit Union Members Pledge Funding for Hospice & Pal..., November 11, 2009
Starbucks Appoints Head of Global Human Resources., November 11, 2009
Stanford study recommends change in treating pulmonary embolisms., November 11, 2009
Spirit Halloween Raises $1 Million to Bring Holiday Celebrations to Ho..., November 11, 2009
SpeechCycle to Participate in BroadSoft Connections 2009 Customer Conf..., November 11, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.